Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 06
2021
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+6.69%
|
$762,000
$381.92 P/Share
|
|
Aug 05
2021
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
2,559
-74.17%
|
$1,535,400
$600.0 P/Share
|
|
Aug 05
2021
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,559
+42.59%
|
$1,000,569
$391.92 P/Share
|
|
Aug 05
2021
|
George Yancopoulos President and Chief Scientific |
SELL
Open market or private sale
|
Direct |
50,000
-5.06%
|
$30,000,000
$600.06 P/Share
|
|
Aug 02
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$577,000
$577.12 P/Share
|
|
Aug 02
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Aug 02
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.05%
|
$57,600
$576.48 P/Share
|
|
Jul 06
2021
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
3,398
-20.49%
|
$1,970,840
$580.0 P/Share
|
|
Jul 02
2021
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
373
-0.26%
|
-
|
|
Jul 02
2021
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
6,602
-28.48%
|
$3,842,364
$582.2 P/Share
|
|
Jul 02
2021
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+30.14%
|
$1,790,000
$179.13 P/Share
|
|
Jul 01
2021
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
2,558
-74.17%
|
$1,470,850
$575.0 P/Share
|
|
Jul 01
2021
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,558
+42.58%
|
$1,000,178
$391.92 P/Share
|
|
Jul 01
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$56,200
$562.35 P/Share
|
|
Jul 01
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$556,000
$556.6 P/Share
|
|
Jul 01
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Jun 25
2021
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
2,084
-70.05%
|
$1,144,116
$549.0 P/Share
|
|
Jun 25
2021
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,084
+41.19%
|
$773,164
$371.4 P/Share
|
|
Jun 24
2021
|
George Yancopoulos President and Chief Scientific |
SELL
Bona fide gift
|
Indirect |
211,585
-100.0%
|
-
|
|
Jun 24
2021
|
George Yancopoulos President and Chief Scientific |
BUY
Bona fide gift
|
Indirect |
211,585
+49.75%
|
-
|
|
Jun 21
2021
|
George Yancopoulos President and Chief Scientific |
SELL
Open market or private sale
|
Indirect |
80,000
-21.7%
|
$43,040,000
$538.04 P/Share
|
|
Jun 14
2021
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Direct |
19,000
-5.81%
|
-
|
|
Jun 14
2021
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1,700
-65.61%
|
$892,500
$525.0 P/Share
|
|
Jun 14
2021
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,700
+39.62%
|
$630,700
$371.4 P/Share
|
|
Jun 14
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$52,500
$525.51 P/Share
|
|
Jun 07
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$511,000
$511.65 P/Share
|
|
Jun 07
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Jun 07
2021
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
1,930
-24.68%
|
$1,013,250
$525.0 P/Share
|
|
Jun 07
2021
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,930
+19.79%
|
$721,820
$374.12 P/Share
|
|
May 27
2021
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Direct |
22,000
-6.3%
|
-
|
|
May 19
2021
|
Leonard S Schleifer President & CEO |
SELL
Bona fide gift
|
Indirect |
41,178
-100.0%
|
-
|
|
May 19
2021
|
Leonard S Schleifer President & CEO |
BUY
Bona fide gift
|
Indirect |
41,178
+50.0%
|
-
|
|
May 17
2021
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
17,521
-16.18%
|
$9,093,399
$519.42 P/Share
|
|
May 14
2021
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
34,979
-28.95%
|
$18,049,164
$516.69 P/Share
|
|
May 14
2021
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
52,500
+29.34%
|
$6,037,500
$115.58 P/Share
|
|
May 07
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$495,000
$495.63 P/Share
|
|
May 07
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Apr 01
2021
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
446
-0.31%
|
-
|
|
Feb 25
2021
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
435
-1.76%
|
-
|
|
Feb 23
2021
|
P Roy Vagelos Director |
SELL
Payment of exercise price or tax liability
|
Direct |
137,998
-28.33%
|
$63,203,084
$458.48 P/Share
|
|
Feb 23
2021
|
P Roy Vagelos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+17.27%
|
$13,000,000
$52.03 P/Share
|
|
Feb 01
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$50,700
$507.82 P/Share
|
|
Jan 25
2021
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
2,480
-73.57%
|
$1,373,920
$554.32 P/Share
|
|
Jan 25
2021
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,480
+42.39%
|
$942,400
$380.95 P/Share
|
|
Jan 19
2021
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
414
-0.29%
|
-
|
|
Jan 12
2021
|
George Yancopoulos President and Chief Scientific |
BUY
Bona fide gift
|
Indirect |
82,108
+50.0%
|
-
|
|
Jan 04
2021
|
Joseph L Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+4.04%
|
-
|
|
Jan 04
2021
|
Arthur F Ryan Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+1.03%
|
-
|
|
Jan 04
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$48,400
$484.54 P/Share
|
|
Jan 04
2021
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
248
+21.77%
|
-
|